You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.

Management of Patients With High-Risk Dyslipidemia: Case Studies

Authors: Khung Keong Yeo, MBBS; Sanjay Kalra, MD; Masahiro Koseki, MD, PhD; Kian Keong Poh, MD, FRCPFaculty and Disclosures


Posted: 28/02/2018

This educational activity is intended for an international audience of non-US cardiologists, diabetologists and endocrinologists, and neurologists

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Screening and identification of patients with high-risk dyslipidemia
    • Latest clinical data for new lipid-lowering therapies, including proprotein convertase subtilisin/kexin type 9 inhibitors, in high-risk dyslipidemia
  • Have increased competence regarding the
    • Selection of optimal lipid-lowering treatments for patients with dyslipidemia based on patient and disease characteristics

Contents of This Activity


Dr Yeo introduces the program and discusses high-risk dyslipidemia in Asia.
Khung Keong Yeo, MBBS

Management of Familial Hypercholesterolemia

Dr Koseki reviews the role of nonstatin therapies in the management of familial hypercholesterolemia.
Masahiro Koseki, MD, PhD

Management of Patients With Dyslipidemia and ASCVD

Dr Kalra outlines best practices for the management of dyslipidemia in patients with clinical CVD.
Sanjay Kalra, MD

Management of Patients Intolerant to Statins

Dr Poh discusses treatment options in patients with dyslipidemia and intolerance to statins.
Kian Keong Poh, MD, FRCP

Pivotal CV Studies: Consequences for Asia

Dr Yeo concludes the program by discussing key studies on the management of high-risk dyslipidemia.
Khung Keong Yeo, MBBS

  • Print